CIK: 1706040 - Address: C/O Keros Therapeutics, Inc., 1050 Waltham Street, Suite 302, Lexington, MA 02421
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/8/22 16:21
4/6/22
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRovaldi ChristopherMAOCOOM.d2816.00020D
4/8/22 16:21
4/6/22
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRovaldi ChristopherMAOCOOS.d-11265.000-2-1000D
4/5/22 16:31
4/1/22
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRovaldi ChristopherMAOCOOM.d1416.00010D
4/5/22 16:31
4/1/22
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRovaldi ChristopherMAOCOOS.d-5057.490-1-1000D
4/4/18 16:41
4/3/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagRovaldi ChristopherMAOSVP,ProgS-13438.400-4-1226D
1/17/18 17:14
1/12/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagRovaldi ChristopherMAOSVP,ProgM.d26524.110118025D
1/17/18 17:14
1/12/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagRovaldi ChristopherMAOSVP,ProgS.d-49545.000-11-3125D
1/4/18 19:05
1/2/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagRovaldi ChristopherMAOSVP,ProgS.m-9642.420-2-825D
9/14/17 17:04
9/12/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagRovaldi ChristopherMAOSVP,ProgS-53838.410-14-3427D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact